This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Konishi, K. Articles by Imawari, M. Search for Related Content PubMed PubMed Citation Articles by Konishi, K. Articles by Imawari, M.

Molecular Differences between Sporadic Serrated and Conventional Colorectal Adenomas

¹ Second Department of Internal Medicine, ² Second Department of Pathology, and ³ Clinical Laboratory, Showa University School of Medicine, Tokyo, and ⁴ Department of Obstetrics and Gynecology, Shimane Medical University, Izumo, Japan

Purpose: The purpose is to compare the molecular characteristics of serrated adenomas (SAs) with those of conventional adenomas (CADs) and hyperplastic polyps (HPs).

Experimental Design: We evaluated the proliferative activity and molecular alterations in 47 SAs (25 pure-type and 22 mixed-type), 71 CADs, and 23 HPs.

Results: The proliferative activity of SAs, as evaluated by Ki-67 expression, was intermediate between CADs and HPs. There was no significant difference in the incidence of KRAS or p53 mutations between the three histological groups. In the microsatellite instability (MSI) analysis, 21% of SAs (9 of 43) showed MSI at two or more loci (MSI-H); corresponding values were 5% of CADs (3 of 64) and 8% of HPs (1 of 13; SAs versus CADs, P = 0.0125). MSI-H was more likely to be found in pure-type SAs (36%; 8 of 22) than in mixed-type SAs (5%; 1 of 21; P = 0.0212). Loss of hMLH-1 expression was found in 8 of 9 SAs with MSI-H. The incidence of BRAF or KRAS mutations was 36 and 15% of SAs, respectively; the combined incidence of BRAF and KRAS mutations occurred in 49% of SAs. However, there was no significant difference in the incidence of BRAF or KRAS mutations between SAs with and without MSI-H.

Conclusions: Genetic instability is more frequently implicated in the tumorigenesis of SAs, especially pure-type SAs, than in that of CADs. In contrast, activation of the Ras/Raf/MEK/MAP kinase cascade by BRAF or KRAS mutation, independently of the genetic instability, may be associated with the progression of about half of SAs.

This article has been cited by other articles:

				J. Vandrovcova, K. Lagerstedt-Robinsson, L. Pahlman, and A. Lindblom Somatic BRAF-V600E Mutations in Familial Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2270 - 2273. [Abstract] [Full Text] [PDF]

				Y. Tajima, K. Yamazaki, R. Makino, N. Nishino, S. Aoki, M. Kato, K. Morohara, T. Kaetsu, and M. Kusano Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin. Cancer Res., November 1, 2006; 12(21): 6469 - 6479. [Abstract] [Full Text] [PDF]